MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.43

-0.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: LJM	5/2/2007 1:08:37 AM
	Read Replies (1) of 2240

Medarex Swings To 1Q Profit On Gain From Sale >MEDX May 1, 2007 16:48:55 (ET) DOW JONES NEWSWIRES Medarex Inc. (MEDX) said late Tuesday it swung to a first-quarter profit of $110.3 million, or 80 cents a share, from a year-ago loss of $36.6 million, or 33 cents a share. The first quarter of 2007 included a gain of $152.1 million, or $1.22 a share, from the February sale of roughly 2.5 million shares of Genmab A/S stock. Excluding the impact of the sale and other items, Medarex reported a loss of $35.9 million, or 29 cents a share. Revenue fell to $11.5 million from $13.1 million in the comparable period last year. Analysts polled by Thomson Financial were expecting, on average, a per-share loss of 37 cents on revenue of $13 million. Medarex is biopharmaceutical based in Princeton, N.J. -Gabriel Madway; 415-439-6400; AskNewswires@dowjones.com (END) Dow Jones Newswires May 01, 2007 16:48 ET (20:48 GMT)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next